Le Lézard
Classified in: Health, Science and technology
Subject: ACC

Increase in share capital in INVISIO due to exercise of stock options


STOCKHOLM, May 31, 2023 /PRNewswire/ -- Due to exercise of outstanding stock options issued to secure delivery of shares under the INVISIO employee stock option program 2020/2023, INVISIO's share capital has increased from SEK 45,048,694 to SEK 45,590,194. This is an increase of SEK 541,500, distributed among 541,500 new shares. The total number of shares and votes in the company thus amounts to 45,590,194.

INVISIO's employee stock option program 2020/2023, adopted by the general meeting of shareholders held on May 5, 2020, gives the company's employees the opportunity to acquire newly subscribed shares. During the period May 15 to June 30 the holders of employee stock options will be entitled to exercise them to acquire new shares in the company.

The employee stock option program is presented in INVISIO's annual report 2022.

For further information, please contact:
Lars Højgård Hansen, CEO, INVISIO
Mobile: + 45 5372 7722 | email: [email protected]

Michael Peterson, Director Investor Relations & Corporate Communication, INVISIO
Mobile: +45 5372 7733 | email: [email protected]

This information is information that Invisio AB (publ) is required to publish pursuant to the Financial Instruments Trading Act. The information was submitted for publication through the CEO, at 08:30 CEST, May 31, 2023.

About INVISIO AB (publ)
INVISIO develops and sells advanced communication systems that enable professionals in noisy and mission critical environments to communicate, protect their hearing and work effectively. The company combines specialist knowledge in acoustics and hearing with broad engineering know-how including in software, materials technology and integration. The company's solutions are marketed under the two brands INVISIO and Racal Acoustics. Sales are via the headquarters in Copenhagen and sales offices in the USA, France, the United Kingdom, Italy and Thailand and via a global network of partners. INVISIO's registered office is in Stockholm and the company is listed on Nasdaq Stockholm (IVSO). Additional information is available on the company's website www.invisio.com.

The following files are available for download:

https://mb.cision.com/Main/17798/3773224/2076015.pdf

Increase in share capital in INVISIO due to exercise of stock options

 


These press releases may also interest you

at 02:00
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful completion of the first two enrollments in the AMEND TS European pilot study.  Dr. Bruno Melica and the team from Vila Nova de Gaia Hospital,...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the quarter ending March 31, 2024. "We are executing our strategy of building on our partnered...

at 00:01
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today debuted the Best Ambulatory Surgery Centers ratings of outpatient surgical centers....

at 00:00
Butterfly Play LLC is dedicated to enhancing the mental and emotional development of children through personalized play skill...

at 00:00
Amygdala Neurosciences (a private company) announced today that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company's IND-stage activities for ANS-858....

at 00:00
Pvolve, the fitness franchise that pairs low-impact, functional movement with resistance equipment to build strong, mobile bodies, is heading to San Francisco, following the franchise's latest development deal for two new studios in the Bay Area with...



News published on and distributed by: